Nationwide Fund Advisors’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-26,498
Closed -$223K 3303
2015
Q4
$223K Buy
26,498
+1,260
+5% +$8.43K ﹤0.01% 2492
2015
Q3
$105K Buy
25,238
+2,692
+12% +$11.8K ﹤0.01% 2882
2015
Q2
$119K Buy
+22,546
New +$144K ﹤0.01% 2970

Nationwide Fund Advisors's OCAT Position: Q1 2016 in Review

Nationwide Fund Advisors sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 26,498 shares — an estimated $223K sold.

Nationwide Fund Advisors first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $223K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Nationwide Fund Advisors reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Nationwide Fund Advisors sold 26,498 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $223K.
  • Nationwide Fund Advisors first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • Nationwide Fund Advisors's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $223K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Nationwide Fund Advisors's 13F filing for Q1 2016, filed 5 May 2016.